Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 579

Document Document Title
WO/2018/124978A1
This present invention relates to a catalyst composition for a production process of δ-lactone from carbon dioxide and 1,3 -butadiene that can efficiently catalyze the synthesis reaction of δ-lactone with good selectivity of δ-lactone...  
WO/2017/155442A1
Disclosed is a production equipment for production of a caprolactone by reaction between peracetic acid, produced from acetic acid and hydrogen peroxide, and cyclohexanone, said equipment being split into a first section (Fig. 1) wherein...  
WO/2017/155441A1
Disclosed is a production equipment for production of a caprolactone by reaction between peracetic acid, produced from acetic acid and hydrogen peroxide, and cyclohexanone, said equipment being split into a first section (Fig. 1) wherein...  
WO/2017/077549A1
The invention discloses a novel analogues of Angiopterlactone B of formula (I) and process for the synthesis thereof. Further the present invention discloses a total synthetic one pot process for the synthesis of Angiopterlactone B and i...  
WO/2016/103677A1
Provided is a method for producing a compound represented by Formula (III) while the production of by-products due to, for example, dimerization of a raw material or isomerization of a double bond position is suppressed. The method is a ...  
WO/2016/079692A1
The instant invention relates to a composition useful as a nutritional supplement comprising acetylated neuraminate (NeuAc), and/or a compound selected from N-acetyl mannosamine (ManNac), at least one or more compounds of the NeuAc biosy...  
WO/2015/073889A1
The present invention provides methods for preparing a C6-C10 alkane, and mixture thereof. The methods include forming a reaction mixture containing an angelica lactone dimer, a catalyst, and a hydrogen source under conditions sufficient...  
WO/2014/159741A1
The present disclosure provides methods for purifying a 5-(halomethyl)furfural composition, including 5-(chloromethyl)furfural, at operating conditions that decrease or minimize the decomposition or degradation of 5-(chloromethyl)furfura...  
WO/2014/140017A1
This invention relates to a novel method for the preparationof 3-oxotetrahydrofurancomprising oxidating 3-hydroxy-tetrahydrofuran in the presence of a catalytic amount of TEMPO with trichloroisocyanuric acid.  
WO/2012/118943A1
The compound according to Formula I is an intermediate in the synthesis of prostacylin analogs. The present invention provides an efficient method for synthesizing a Formula I compound.  
WO/2012/027521A1
Molecules having the following structure are disclosed. Processes of using such molecules are disclosed.  
WO/2010/115798A3
The invention relates to a method for producing 1,6-hexanediol and caprolactone, preferably of at least 99.5% purity, which are especially substantially free from 1,4 cyclohexanediols, starting from a carboxylic acid mixture which is obt...  
WO/2009/126852A1
An enhanced process for the production of a dianhydrosugar, such as isosorbide, from the corresponding sugar alcohol is described. The sugar alcohol is combined with an acid catalyst and reacted at elevated temperatures and at atmospheri...  
WO/2009/105969A1
The invention discloses novel epothilone analogues, their pharmaceutical compositions, their use and their preparations, especially discloses the compounds of the following formula, their preparations and their use for preparing therapeu...  
WO/2009/105969A8
The invention discloses novel epothilone analogues, their pharmaceutical compositions, their use and their preparations, especially discloses the compounds of the formula (I), their preparations and their use for preparing therapeutical ...  
WO/2009/105755A3
The present invention includes macrocyclic prodrug compounds, pharmaceutical compositions containing them. The present invention also includes use of these compounds in the treatment of various diseases including an autoimmune disease, a...  
WO/2009/042708A1
A regenerative anti-inflammatory composition is described to include 1 to 2 percent of comenic acid and 0.55 to 1.1 percent of sodium hydrocarbonate in a water solution, with an optional additive of up to 2.5 percent of benzyl-comenic ac...  
WO/2008/081568A1
Disclosed are: a novel dinoflagellate alga; and a macrolide compound which can be used as a novel anti-cancer agent. Specifically disclosed is a macrolide compound produced by a dinoflagellate Amphidinium sp. strain HYA002 or HYA0024. Th...  
WO/2008/046790A1
The present invention relates to a method for producing lactones from optionally substituted, saturated aliphatic diols comprising 5 to 20 carbon atoms between both ring-closing hydroxyl groups by catalytic dehydration and cyclization in...  
WO/2008/026140A2
The invention relates to a malodor counteractancy or counteracting (MOC) method that resorts to the use of specific malodor counteracting (MOC) mixtures of fragrance ingredients. More particularly, the invention relates to new MOC compos...  
WO/2008/026140A3
The invention relates to a malodor counteractancy or counteracting (MOC) method that resorts to the use of specific malodor counteracting (MOC) mixtures of fragrance ingredients. More particularly, the invention relates to new MOC compos...  
WO/2008/020830A1
A method of treating or reducing the probability of an Aspergillus or Cryptococcus infection in a subject in need of such treatment or reduction of probability, comprising administering to the subject a pharmaceutical composition compris...  
WO/2007/149543A2
A method for treating a scar comprises administering to a scar a pharmaceutically effective amount of one or more blistering agents in a pharmaceutically acceptable carrier.  
WO/2007/054429A1
A process is described for the production of an (E,Z)-10,11 ,12-pentadecen-15-olide isomer mixture, which process comprises the following step: partial isomerisation of (E1Z)-H - and/or (E,Z)-12-pentadecen-15-olide, such that the (E1Z)-(...  
WO2006017409A3
Compounds represented by Formula I: (wherein A, B, D, P, Q, R1, R2, R3, W and Y are described herein) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such a...  
WO/2006/046140A2
The present invention relates to a process for preparing a lactone. The process comprises the steps of reacting an aldehyde with an organic halide in a carbon chain extension reaction to form an alcohol compound comprising a functional g...  
WO/2006/046140A3
The present invention relates to a process for preparing a lactone. The process comprises the steps of reacting an aldehyde with an organic halide in a carbon chain extension reaction to form an alcohol compound comprising a functional g...  
WO/2006/043075A1
This invention relates to the selective oxidation of organic compounds. According to the invention organic compounds are selectively oxidized using a peracid or a source of peracid, a transition metal based heterogeneous catalysts and a ...  
WO/2006/007523A1
This invention relates to a process for catalytically hydrogenating a hydrogenatable precursor in contact with a hydrogen-containing gas and a hydrogenation catalyst comprising one or more active hydrogenation catalyst components on a su...  
WO/2005/113533A9
The invention relates to a process for preparing saturated or unsaturated lactones. This process involves reacting a bicyclic compound or a monocyclic compound with hydrogen peroxide in the presence of a first acid having a pKa of 3 or l...  
WO/2005/113533A1
The invention relates to a process for preparing saturated or unsaturated lactones. This process involves reacting a bicyclic compound or a monocyclic compound with hydrogen peroxide in the presence of a first acid having a pKa of 3 or l...  
WO/2005/103065A1
The present invention relates to new anthracycline derivatives and their use in cancer therapy and diagnosis. These anthracycline derivatives can be radiolabelled and used as an imaging agent in cancer diagnosis. The radiolabelled anthra...  
WO2005035489A8
Processes for synthesizing a compound of Formula (I) are provided by reacting a compound of Formula (i) with a compound of Formula (xx).  
WO2005079471A3
A compound or groups of compounds, present in an active principle, derived from tunicates of the species Synoicum adareanum, as well as to pharmaceutical compositions comprising these compounds. Extracts from tunicates show selective tox...  
WO/2005/079471A2
A compound or groups of compounds, present in an active principle, derived from tunicates of the species Synoicum adareanum, as well as to pharmaceutical compositions comprising these compounds. Extracts from tunicates show selective tox...  
WO2005035489A3
Processes for synthesizing a compound of Formula (I) are provided by reacting a compound of Formula (i) with a compound of Formula (xx).  
WO/2005/061481A1
The present invention relates to compounds having the structure (and pharmaceutically acceptable derivatives thereof) (I) wherein R,,-R4, Z, X, A-B, D-E, G-J, and K-L are as defined herein, the synthesis thereof and the use of these comp...  
WO/2005/058491A1
The invention relates to a catalyst provided in the form of an extrudate, which contains 5 to 85 % by weight of copper oxide and comprises, in the active material and as binders, the same oxidic carrier material. The invention also relat...  
WO/2005/051875A1
A homogeneous process for the hydrogenation of dicarboxylic acids and/or anhydrides in the presence of a catalyst comprising: (a) ruthenium, rhodium, iron, osmium or palladium; and (b) an organic phosphine; wherein the hydrogenation is c...  
WO2004083170A3
Compounds of formula (1) wherein R1 is hydrogen, hydroxy, halogen, nitro, cyano, amino, carboxy, carboxylic ester, sulfo, sulfonic ester, carboxylic amide, sulfonic amide, alkoxy, aryloxy, alkylthio or arylthio, X is -0-, -S-, -NH- or -N...  
WO/2005/035489A2
Processes for synthesizing a compound of Formula (I) are provided by reacting a compound of Formula (i) with a compound of Formula (xx).  
WO/2005/035519A1
The invention relates to a method for producing 1-hydroperoxy-16-oxabicyclo[10.4.0]hexadecane (DDP-OOH), according to which 13-oxabicyclo[10.4.0]hexadec-1(12)-ene (DDP) and hydrogen peroxide are reacted in a diluent in the presence of a ...  
WO2005014565A3
The present invention relates to an improved process to prepare cis-3-dihydrocarbylmethano-5-hydrocarbyldihydro-furan-2-ones . The present invention also relates to novel compositions of matter comprising enantiomerically pure cis-3-dihy...  
WO/2005/014569A1
The present invention pertains to a novel process for the preparation of lactones by decomposition of a 1,2,4-­trioxepane of formula (I) wherein, R is H or CH3, n is 1-14, Rx independently is any substituent on the ring structure, inclu...  
WO/2005/014565A2
The present invention relates to an improved process to prepare cis-3-dihydrocarbylmethano-5-hydrocarbyldihydro-furan-2-ones . The present invention also relates to novel compositions of matter comprising enantiomerically pure cis-3-dihy...  
WO/2004/089923A1
The present invention pertains to a process for the carbonylation of an epoxide by reacting it with carbon monoxide in the presence of a catalyst system containing two components, wherein the first component is a source of one or more me...  
WO/2004/083170A2
Compounds of formula (1) wherein R1 is hydrogen, hydroxy, halogen, nitro, cyano, amino, carboxy, carboxylic ester, sulfo, sulfonic ester, carboxylic amide, sulfonic amide, alkoxy, aryloxy, alkylthio or arylthio, X is -0-, -S-, -NH- or -N...  
WO/2004/078738A1
The present invention relates to a process for the oxidation, in an inert solvent, of a non-aromatic or non-enonic ethylenic bond or of a non-conjugated cyclic ketones into the corresponding epoxides, respectively lactone, using H?2#191O...  
WO/2004/065402A1
The invention relates to derivatives of 9-ketospinosyn derivatives, which are substituted in the C-9 position by a radical =N-(O, NH or NRx)-Ry, to a method for the production thereof, and to their use for controlling animal pests.  
WO2004037757A3
A process for production of tetrahydrofuran, gamma butyrolactone, 1,4 butanediol and the like from a hydrogenatable precursor such as maleic acid, succinic acid, corresponding esters and their mixtures and the like in an aqueous solution...  

Matches 1 - 50 out of 579